MGM Resorts upgraded to Outperform from Neutral at Credit Suisse 04:52 MGM Credit Suisse analyst Benjamin Chaiken upgraded MGM Resorts to Outperform from Neutral with a price target of $68, up from $33. The company has "gone through a transformation," recently announcing four transactions, that the market is not giving it full credit for, Chaiken tells investors in a research note. He now sees MGM as a "cleaner more simplified organization" with a more attractive capital structure. Chaiken believes MGM to can beat consensus estimates.
Nike initiated with a Buy at Goldman Sachs 04:48 NKE Goldman Sachs analyst Kate McShane initiated coverage of Nike with a Buy rating and $172 price target. The analyst sees a "healthy industry backdrop with a company-specific continued focus on innovation to drive growth." Nike has room to expand its direct-to-consumer initiative, which should drive higher gross margins over time, McShane tells investors in a research note. In addition, its high cash balance should enable additional investment and capital return to shareholders. Sourcing concerns are transitory and likely priced in following the recent selloff, contends McShane. Amyris call volume above normal and directionally bullish 15:45 AMRS Bullish option flow detected in Amyris with 4,255 calls trading, 1.0x expected, and implied vol increasing almost 5 points to 79.58%. 11/26 weekly 16 calls and Oct-21 12.5 calls are the most active options, with total volume in those strikes near 2,000 contracts. The Put/Call Ratio is 0.12. Earnings are expected on November 4th. AC approval 'an important milestone' for Ocular's pipeline, says Piper Sandler 15:26 OCUL Piper Sandler analyst Joseph Catanzaro notes that Ocular Therapeutix announced FDA approval of Dextenza's sNDA for the treatment of ocular itching associated with allergic conjunctivitis. While the immediate commercial impact from this label is likely modest, it has important downstream implications for Ocular's front of the eye intracanalicular pipeline, the analyst contends. Catanzaro also notes that the AC label represents Dextenza's formal move into the office setting and will allow Ocular to prime the anterior segment market around the potentially favorable reimbursement dynamics with using an intracanalicular insert, namely procedure fees and buy-and-bill that could provide significant economic incentives for physicians and their offices. Along these lines Phase IIb dry eye data for OTX-CSI are expected this quarter and will be another significant catalyst for Ocular and the potential for its future front of the eye business, he adds. The analyst has an Overweight rating and a price target of $27 on the shares.
ISRAEL GOES DRONE. Tests above Tel Aviv! Israel moves ahead with national drone network Oct. 12, 2021 4:06 AM ETUnited Parcel Service, Inc. (UPS),GOOG,AMZN,WMTUAVS,AMBA,AVAV,DJI,HON,TRMB,GOOGL Orders of sushi, beer and ice cream flew across the Tel Aviv coast on Monday as part of a government-led initiative to create a national drone network. The project intends to ease road congestion, improve air quality and be an economically viable option for the 9.2M consumers around the country. Flights have also been used for medical purposes, like delivering donated blood and plasma, though officials must ensure the skies could be cleared in case of turbulent weather, a war or an emergency. Phase 3:The National Drone Initiative has a total of eight planned phases, with the latest stage conducting around 300 flights per day above open areas. The UAVs can currently carry a maximum load of approximately 2.5 kg (5.5 pounds) and have a 5-kilometer (3-mile) radius for missions, though the Israel Innovation Authority said that by next year the perimeter will be expanded to 100-kilometers (60 miles). Many of the 16 participating companies have links to Israel's military, which is a global leader in drone technology. It's garnering "a lot of interest from other countries and regulators, as we are now far ahead,"said Sagi Dagan, Vice-President of Growth at the Israel Innovation Authority. "Israel has a competitive advantage in terms of the technologies, the drones and the air traffic management, all being co-designed through regulation and the market, and setting the new rules through work in the field. This is very unique." Over in the U.S.:Last December,the FAA introduced new drone rules to help open the skies for widespread commercial deliveries, allowing operators to fly small drones over people and at night under certain conditions. The regulations give the agency and law enforcement a handle on what's actually flying around, requiring remote identification technology to pinpoint UAVs from the ground. Drones represent the fastest-growing segment in the entire transportation sector, with over 866K drone registrations and 247K FAA-certificated remote pilots. Some history:UPS(NYSE:UPS) won the government's first full approval to operate a drone delivery airline back in October 2019, while Alphabet's (GOOG,GOOGL) Wing became the first company to get certification for a single-pilot drone operation. In August 2020, the FAA granted Amazon(NASDAQ:AMZN)permission for delivery trials, while Walmart(NYSE:WMT)jumped into the drone delivery race that September. Earlier this year, Google also sought approval to use drones to research firefighting in Californiaand CVS (CVS) partnered with UPS to deliver prescriptions in Florida. (Compare performance of the rivals here). Related commercial drone stocks:AMBA,HON,TRMB,UAVS UAVS AgEagle Aerial Systems, Inc. 2.80 -0
Freyr Battery soars after lining up gigafactory partner, attracting Credit Suisse bull rating Credit Suisse launches coverage on Freyr Battery(NYSE:FREY) with an Outperform rating. Analyst Maheep Mandloi thinks Freyr's (FREY) plans to manufacture cost-competitive lithium-ion battery cells in Norway are strategic. Freyr is seen benefiting from a licensing agreement with 24M Technologies and a battery storage market called robust and growing. The availability of low-cost renewables in the Nordic ecosystem is also noted. Credit Suisse assigns a price target of $13 to FREY. Shares of FREY are up 11.24% to $10.79 premarket after the company formed a joint venture with Koch Strategic Platforms earlier in the day. Vroom to buy United Auto Credit Corporation for $300M in cash deal Online Automotive Retailer Vroom(NASDAQ:VRM) has agreed to acquire California based United Auto Credit Corporation (UACC) for $300M in cash. UACC is a leading, nationwide technology-enabled non-prime auto lender serving the independent dealer market. The deal accelerates Vroom’s entry into captive financing operations and expands opportunity for consumers across the credit spectrum to transact on Vroom’s platform. Pursuant to the deal, UACC will become an indirect wholly-owned subsidiary of Vroom and will continue to operate under the UACC name. Jim Vagim, President and Chief Executive Officer of UACC, and Ravi Gandhi, Managing Director and CFO of UACC, will remain in their positions following the acquisition and play a key role in the integration and execution of Vroom's captive finance strategy. The company will finance the purchase price through cash on hand. The acquisition is expected to immediately be accretive to Vroom's earnings. The transaction is expected to close either late in the fourth quarter of 2021 or early in the first quarter of 2022, subject to receipt of required regulatory approvals and satisfaction of customary closing conditions. Conference Call on October 12, 2021 at 8:30 am ET.
Bentley Systems and SMRT Trains to jointly improve safety and reliability of metro rail services in Singapore Bentley Systems(NASDAQ:BSY)and Strides Engineering hasinkedMoU agreement to jointly market a rail predictive maintenance solution in the Asia Pacific Region. As per the agreement, Bentley Systems will continue to sell, implement, and support its AssetWise solution while Strides Engineering will market and deliver its domain experience and add-on applications for track maintenance. The company and SMRT Trains, Mass Rapid Transit (MRT) operator in Singapore, have successfully completed the implementation of a Predictive Decision Support System (PDSS) for Singapore’s North-South and East-West lines, the oldest MRT lines in the country. Gan Boon Jin, president of Strides Engineering, said, “Strides Engineering’s collaboration with Bentley Systems on the PDSS demonstrates a firm partnership in combining strong domain and rail operational capabilities with proven technological expertise. The PDSS will enhance and optimize decision-making in rail maintenance. We look forward to bringing the best practices and results of PDSS to other train operators in the region.” Down from $70. Now--> $57.
We don't want to lose track of this one-- Amicus Therapeutics, Inc. (FOLD)-This was $10.10 last week NasdaqGM - NasdaqGM Real Time Price. Currency in USD NOW---<$11.67
Now, key money managers have been driving this bullishness. Great Point Partners, managed by Jeffrey Jay and David Kroin, established the biggest position in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Great Point Partners had $15.4 million invested in the company at the end of the quarter. Bhagwan Jay Rao's Integral Health Asset Management also made a $9.2 million investment in the stock during the quarter. The other funds with brand new FOLD positions are Efrem Kamen's Pura Vida Investments, Christiana Goh Bardon's Burrage Capital Management, and Sander Gerber's Hudson Bay Capital Management.
I don't know how I do it... but you should just take notes. $11.25 close, $11.15 after hours. Van it's freakin' $11.50 are you looking at he right stock!--OCUL
Yesterdays scalp is still going strong!!! BROS-- Was $42-$43 Dutch Bros Inc. (BROS)- $46---> $48.25 SCALP/ I am OUT! But..... NYSE - NYSE Delayed Price. Currency in USD Add to watchlist Visitors trend2W 49.00+6.35 (+14.89%) At close: October 11 4:00PM EDT 49.67+0.67 (+1.37%)<--------------- Pre-Market:08:10AM EDT Van I see you bitching about this would you like to provide us all with a $2 trade today.. Please do.....